Triglyceride to HDL Ratio Management

Patient Assessment and Risk Stratification

The American College of Cardiology recommends screening for hypothyroidism, poorly controlled diabetes, and chronic kidney disease as these conditions elevate triglycerides, and reviewing medications that raise triglycerides, such as thiazide diuretics and beta-blockers, except carvedilol, in patients with elevated triglyceride to HDL cholesterol ratios 1
Assessing alcohol intake and mandating complete abstinence if excessive is crucial, as alcohol significantly elevates triglycerides, especially with high saturated fat intake, according to the American Heart Association 1, 2

The American College of Cardiology suggests restricting total dietary fat to 20-25% of total calories, eliminating added sugars and refined carbohydrates, and targeting 5-10% body weight reduction in overweight or obese individuals to reduce triglycerides by approximately 20% 2, 3
Prescribing at least 150 minutes weekly of moderate-intensity aerobic activity, limiting saturated fat intake, and eliminating trans fats while increasing omega-3 fatty acids from marine sources are recommended by the American Heart Association 2, 3
For moderate hypertriglyceridemia with low HDL-C, initiating fenofibrate 54-160 mg daily as first-line therapy, which reduces triglycerides by 30-50% and increases HDL cholesterol, is recommended by the American College of Cardiology 3, 4

Targeting triglycerides <150 mg/dL, ideally <100 mg/dL for optimal metabolic health, and HDL-C >40 mg/dL in men and >50 mg/dL in women, with rechecking of fasting lipid panel in 4-8 weeks after initiating therapy, is recommended by the American College of Cardiology 2, 3, 4
Monitoring liver function tests and creatine kinase at baseline and during treatment with fibrates or combination therapy, and once goals are achieved, monitoring every 6-12 months, is suggested by the American Heart Association 2, 3, 4

The American Heart Association emphasizes that non-HDL-C provides better risk estimation in patients with elevated triglycerides, diabetes, or metabolic syndrome, and the TG/HDL-C ratio identifies more at-risk individuals than metabolic syndrome criteria alone 6
The 2021 ACC Expert Consensus recommends using elevated triglycerides as a risk-enhancing factor in primary prevention to guide statin initiation, according to the American College of Cardiology 5